Literature DB >> 23613015

Current insights into animal models of Graves' disease and orbitopathy.

B Wiesweg1, K T M Johnson, A K Eckstein, U Berchner-Pfannschmidt.   

Abstract

Graves' disease (GD) is a systemic autoimmune disease that is characterized by hyperthyroidism, orbitopathy and in rare cases dermopathy. Graves' orbitopathy (GO) is an inflammatory disease of eye and orbit which occurs in about 30-60% of patients. Hyperthyroidism occurs due to the presence of stimulating TSHR-autoantibodies (TRAbs) leading to increased serum levels of thyroid hormones. Attempts to induce Graves' disease in mice by immunization against the hTSHR or its variants have resulted in production of TRAbs that stimulate thyroid follicular cells to increase thyroid hormone secretion. Graves' like orbital changes, such as inflammation, adipogenesis and muscle fibrosis are more difficult to induce. In this review we summarize different methods used to induce murine Graves'-like disease and their impact on murine orbits. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23613015     DOI: 10.1055/s-0033-1343451

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  8 in total

Review 1.  Total thyroid ablation in Graves' orbitopathy.

Authors:  F Menconi; M Leo; P Vitti; C Marcocci; M Marinò
Journal:  J Endocrinol Invest       Date:  2015-03-05       Impact factor: 4.256

2.  Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.

Authors:  A Schlüter; M Horstmann; S Diaz-Cano; S Plöhn; K Stähr; S Mattheis; M Oeverhaus; S Lang; U Flögel; U Berchner-Pfannschmidt; A Eckstein; J P Banga
Journal:  Clin Exp Immunol       Date:  2017-11-17       Impact factor: 4.330

3.  Development of a Novel Thyroid Function Fluctuated Animal Model for Thyroid-Associated Ophthalmopathy.

Authors:  Yunhai Tu; Yilong Wang; Luna Ding; Jiao Zhang; Wencan Wu
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

4.  Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.

Authors:  Nan Xia; Xiaozhen Ye; Xiaohao Hu; Shiyu Song; Hui Xu; Mengyuan Niu; Hongwei Wang; Jian Wang
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

5.  Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.

Authors:  Sajad Moshkelgosha; Hedda Luise Verhasselt; Giulia Masetti; Anja Eckstein; Marian Ludgate; Utta Berchner-Pfannschmidt; Danila Covelli; Filippo Biscarini; Mareike Horstmann; Anke Daser; Astrid M Westendorf; Christoph Jesenek; Svenja Philipp; Salvador Diaz-Cano; J Paul Banga; Daryn Michael; Sue Plummer; Julian R Marchesi
Journal:  Microbiome       Date:  2021-02-16       Impact factor: 14.650

6.  Noninflammatory Diffuse Follicular Hypertrophy/Hyperplasia of Graves Disease: Morphometric Evaluation in an Experimental Mouse Model.

Authors:  Anke Schlüter; Anja K Eckstein; Alexandra Brenzel; Mareike Horstmann; Stephan Lang; Utta Berchner-Pfannschmidt; J Paul Banga; Salvador Diaz-Cano
Journal:  Eur Thyroid J       Date:  2018-04-13

7.  Graves' orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model.

Authors:  Anke Schlüter; Ulrich Flögel; Salvador Diaz-Cano; Gina-Eva Görtz; Kerstin Stähr; Michael Oeverhaus; Svenja Plöhn; Stefan Mattheis; Lars C Moeller; Stephan Lang; Nikolaos E Bechrakis; J Paul Banga; Anja Eckstein; Utta Berchner-Pfannschmidt
Journal:  Sci Rep       Date:  2018-08-30       Impact factor: 4.379

8.  Characterization of a Murine Model of Oxazolone-Induced Orbital Inflammation.

Authors:  Dhanesh Amarnani; Angie V Sanchez; Lindsay L Wong; Brandon V Duffy; Leslie Ramos; Suzanne K Freitag; Diane R Bielenberg; Leo A Kim; Nahyoung Grace Lee
Journal:  Transl Vis Sci Technol       Date:  2020-07-16       Impact factor: 3.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.